Storia in 13 fonti

Hype for Moderna’s cancer vaccine is running ahead of the math

Personalized mRNA shots may prove neither as wide-reaching nor as lucrative as hoped.

Raccontata da

hindustantimes.com+1 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

hindustantimes.comStai leggendo3 g fa

Hype for Moderna’s cancer vaccine is running ahead of the math

Personalized mRNA shots may prove neither as wide-reaching nor as lucrative as hoped.

originale

Timeline cronologica

statnews.com

2 g fa

Inside Moderna and Merck’s cancer vaccine triumph

Moderna and Merck's wild gambit on a cancer vaccine appears to have worked, despite big doubts, logistical challenges, and pandemic-era complications.

Leggi questa versione → originale

investors.com5 g fa

Moderna Is Just The Start: Why AI-Focused Money Might Flow Into Biotech

Moderna stock catches the eye of investors looking for the next big AI play.

Leggi questa versione → originale

pbs.org6 g fa

Moderna shares surge after it says experimental mRNA cancer treatment passed key test

Moderna and Merck are developing a treatment using an mRNA-based cancer vaccine called intismeran that is designed to be tailored to individual patients based on unique mutations within their tumors.

Leggi questa versione → originale

morningstar.com5 g fa

Health Care Down as Moderna Gives Back Some Gains - Health Care Roundup

Health-care companies fell as euphoria about a breakthrough in RNA-based medicine faded.

Leggi questa versione → originale

expansion.com5 g fa

Moderna desata la euforia en los mercados

Moderna se dio a conocer en el campo de las enfermedades infecciosas y, desde la pandemia, ha buscado con urgencia una nueva especialidad. Este mi�rcoles lo consigui�: su vacuna...

Leggi questa versione → originale

giovedì 20 agosto 2026·

benzinga.com

Moderna's Intismeran Close to Keytruda Style Oncology Opportunity: Analyst - Moderna (NASDAQ:MRNA)

William Blair upgraded Moderna to Outperform, citing higher intismeran approval odds and a multibillion-dollar oncology sales opportunity.

giovedì 20 agosto 2026·

ft.com

Moderna breakthrough brings back memories of pandemic mania

Biotech nearly triples as mRNA cancer treatment shows promise after company had struggled in recent years

giovedì 20 agosto 2026·

expansion.com

Moderna desata la euforia en los mercados

Moderna se dio a conocer en el campo de las enfermedades infecciosas y, desde la pandemia, ha buscado con urgencia una nueva especialidad. Este mi�rcoles lo consigui�: su vacuna...

giovedì 20 agosto 2026·

publico.es

Mucha expectación, pocos datos y euforia en Bolsa: qué se sabe de la vacuna del melanoma de Moderna y MSD

El fármaco diseñado ha dado resultados positivos en un ensayo clínico de fase III, el paso previo a su comercialización.

venerdì 21 agosto 2026·

morningstar.com

Health Care Down as Moderna Gives Back Some Gains - Health Care Roundup

Health-care companies fell as euphoria about a breakthrough in RNA-based medicine faded.

venerdì 21 agosto 2026·

cnn.com

Moderna, Merck breakthrough could usher in wave of cancer vaccines | CNN

Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of treatment that doctors hope will work against many types of…

venerdì 21 agosto 2026·

channelnewsasia.com

CNA Explains: What we know about the Moderna, Merck breakthrough cancer vaccine

The personalised vaccine has succeeded in a final-stage melanoma trial. Here’s how it works, when it could become available and why researchers hope the approach can be used…

venerdì 21 agosto 2026·

investors.com

Moderna Is Just The Start: Why AI-Focused Money Might Flow Into Biotech

Moderna stock catches the eye of investors looking for the next big AI play.

venerdì 21 agosto 2026·

bostonglobe.com

A ‘paradigm shift’: Moderna cancer vaccine results could herald new world of treatment - The Boston Globe

The vaccine, tailor-made to the genetic sequence of a patient’s cancer and paired with existing treatment, has the potential to be a game-changer.

domenica 23 agosto 2026·

hindustantimes.com

Hype for Moderna’s cancer vaccine is running ahead of the math

Personalized mRNA shots may prove neither as wide-reaching nor as lucrative as hoped.

lunedì 24 agosto 2026·

statnews.com

Inside Moderna and Merck’s cancer vaccine triumph

Moderna and Merck's wild gambit on a cancer vaccine appears to have worked, despite big doubts, logistical challenges, and pandemic-era complications.

Hype for Moderna’s cancer vaccine is running ahead of the math

Timeline cronologica

Moderna shares surge after it says experimental mRNA cancer treatment passed key test

Moderna says skin cancer vaccine trial a success

Inside Moderna and Merck’s cancer vaccine triumph

Moderna Is Just The Start: Why AI-Focused Money Might Flow Into Biotech

Moderna shares surge after it says experimental mRNA cancer treatment passed key test

Health Care Down as Moderna Gives Back Some Gains - Health Care Roundup

Moderna desata la euforia en los mercados

Moderna's Intismeran Close to Keytruda Style Oncology Opportunity: Analyst - Moderna (NASDAQ:MRNA)

Moderna breakthrough brings back memories of pandemic mania

Moderna desata la euforia en los mercados

Mucha expectación, pocos datos y euforia en Bolsa: qué se sabe de la vacuna del melanoma de Moderna y MSD

Health Care Down as Moderna Gives Back Some Gains - Health Care Roundup

Moderna, Merck breakthrough could usher in wave of cancer vaccines | CNN

CNA Explains: What we know about the Moderna, Merck breakthrough cancer vaccine

Moderna Is Just The Start: Why AI-Focused Money Might Flow Into Biotech

A ‘paradigm shift’: Moderna cancer vaccine results could herald new world of treatment - The Boston Globe

Hype for Moderna’s cancer vaccine is running ahead of the math

Inside Moderna and Merck’s cancer vaccine triumph